AstraZeneca recently announced positive results from an interim analysis of clinical trials testing its COVID-19 vaccine, AZD1222, in the UK and Brazil.
Specifically, AZD1222 met the primary...
An American Heart Association study recently found that patients taking cholesterol-lowering statin medication and patients taking a placebo reported the same side effects.
Specifically,...
COVID-19 drug discovery efforts for early treatment of the virus in mild to moderate cases of the virus have been lacking even though successes now could mitigate the impact future outbreaks have on...
Boston Children’s Hospital and Deerfield Management Company recently announced a research collaboration aimed at advancing drug discovery and development to address rare and complex pediatric...
FDA recently issued an emergency use authorization for Eli Lilly & Company’s COVID-19 antibody treatment for use in mild to moderate coronavirus in adults and pediatric patients.
The...
FDA recently authorized the first COVID-19 serology test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection.
The emergency use authorization went to biotechnology...
Specialty drugs accounted for 37.7 percent of retail and mail order prescription spending net of rebates in 2016-2017, a recent Health Affairs study found.
Researchers leveraged nationally...
Last week, states began to report what communities they will distribute Abbott’s BinaxNOW COVID-19 test to assist ongoing reopening efforts.
Back in August, the Trump Administration announced it...
Recently, Epic has prioritized broad pharmacy development. A recent KLAS report, Epic Pharmacy, looked to validate if this is the right move for Epic’s customers and where gaps may...
HHS and the Department of Defense (DoD) recently announced an agreement with Eli Lilly and Company to purchase the first doses of the company’s COVID-19 antibody therapeutic, LY-CoV555.
The...
Thermo Fisher Scientific recently expanded its direct-to-patient clinical trial service offerings to support decentralized clinical trials, minimize length and costs, and increase patient enrollment...
Bayer recently announced a $4 billion pharma acquisition deal with Asklepios BioPharmaceutical (AskBio) to broaden its base in cell and gene therapy.
As part of the acquisition deal, Bayer...
Insulin prices are more than eight times higher in the US than in 32 comparable, high-income nations combined, according to a new RAND Corporation study.
In the analysis, researchers used...
FDA recently issued guidance to provide recommendations for vaccine sponsors regarding the data and information that would support an emergency use authorization (EUA) for a COVID-19 vaccine.
Chief...
Johnson & Johnson recently announced the completion of a $6.5 billion pharmaceutical acquisition deal involving biotechnology company Momenta Pharmaceuticals, Inc.
This announcement comes a...
HHS and The Rockefeller Foundation recently signed an agreement to identify and share effective approaches for increasing rapid point-of-care (POC) COVID-19 testing in various communities.
Under...
Bristol Myers Squibb recently announced that its immunotherapy, Opdivo (nivolumab), improved disease-free survival versus a placebo for patients with high-risk, muscle-invasive bladder cancer in a...
Bristol Myers Squibb and bluebird bio, Inc. recently announced that FDA accepted their request for a priority review for Idecabtagene vicleucel, a chimeric antigen receptor (CAR) T-cell therapy for the...
Sixty-four higher-income economies recently joined the COVAX Facility, a global COVID-19 response effort that ensures governments and manufacturers have access to COVID-19 vaccines, according to an...
Roche recently announced the launch of its new COVID-19 antibody test, Elecsys Anti-SARS-CoV-2 S, for markets accepting the CE Mark.
The serology test will measure the number of antibodies to the...
